Technology and Computers: BioTechnology Press Releases

Primerdesign Launch World's Most Affordable DNA Testing System

Primerdesign is a spinoff company from the University of Southampton specialising in Real-Time PCR technology. As well as solving challenging problems for researches they also manufacture an extensive range of 'genesig' pathogen and disease testing kits. Furthermore the genesig range has animal speciation kits which were in high demand during the 2013 horse-meat scandal. Finally in 2009 Primerdesign were the first company in the world to develop a detection kit for H1N1 swine flu.

Katarina Radosevic, Janssen to Present at Vaccines Conference on July 9-11, 2014, in Boston, MA

Katarina Radosevic, Vice President Immunology and Proof of Concept, Head Vaccine Discovery at Crucell Vaccine Institute, Janssen Center of Excellence for Immunoprophylaxis will give a presentation on, "Prospects for Universal Influenza Vaccine" at the 12th Vaccines Research & Development: All Things Considered Conference on July 9-11, 2014, in Boston, MA, by GTCbio. Approximately 1 billion people worldwide get infected with influenza virus on a yearly basis, leading to severe illness in 3-5 million cases and an estimated 300,000 to 500,000 influenza-related deaths.

Chih-Jen (CJ) Wei, Sanofi Pasteur to Present at Vaccines Conference on July 9-11, 2014, in Boston, MA.

Chih-Jen (CJ) Wei, Director at Sanofi Pasteur will give a presentation on, "A Self-Assembling Influenza Nanoparticle Vaccine Elicits Broad and Potent Neutralizing Antibodies" at the 12th Vaccines Research & Development: All Things Considered Conference on July 9-11, 2014, in Boston, MA, by GTCbio. Influenza viruses pose a significant threat to the public and are a burden on global health systems.

Global In Vitro Diagnostics (IVD) Market

In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.

Joseph Joyce, Merck to Speak at Vaccines Meeting on July 9-11, 2014, in Boston

Joseph G. Joyce, Director of Vaccine Process Development at Merck Research Laboratories will give a presentation on "Development and Immunogenicity of a 15-Valent Polysaccharide-Protein Conjugate Vaccine for Prevention of Invasive Pneumococcal Disease" at the 12th Vaccines Research & Development: All Things Considered Conference on July 9-11, 2014, in Boston, MA by GTCBio.

Ralph Tripp to Present at Influenza Conference on July 9-11, 2014, in Boston, MA

Ralph Tripp, Professor and Georgia Research Alliance Chair in Vaccine and Therapeutic Development at the University of Georgia will give a presentation on "Understanding the Influenza Virus - Host Interface to Advance Mammalian Vaccine Cell Line Development and Novel Therapeutics" at the 3rd Annual Influenza Research and Development Conference on July 9-11, 2014 in Boston, MA by GTCBio. Influenza virus is a worldwide global health concern causing seasonal morbidity, mortality, and economic burden.

Robert Webster to Keynote at Influenza Meeting on July 9-11, 2014, in Boston, MA

Robert G. Webster, Rose Marie Thomas Chair, Division of Virology, Department of Infectious Diseases, St. Jude Children's Research Hospital To Give a Keynote Presentation on "The Continued Threat of H5N1, H7N9 and H9N2 Influenza Viruses to a One World System" at the 3rd Annual Influenza Research and Development Conference on July 9-11, 2014, in Boston, MA

David Merberg to Speak at Bioinformatics Conference Jun 19-20 2014, San Diego, CA

David Merberg, Ph.D., Bioinformatics Scientist in the Translational Bioinformatics Group at Takeda Pharmaceuticals will give a presentation titled "A Computing Infrastructure to Bridge the Gap between Preclinical and Clinical Studies" at the Bioinformatics & Pharmacogenomics: Managing and Analyzing Big Data Conference to be held in San Diego, CA on June 19-20, 2014 by GTCBio.

John Herrmann to Speak at 3rd Oncology Partnering and Deal-Making Conf - July 7-8, 2014 in Boston

John Herrmann, Chief Science Officer of Global External Research & Development, Oncology at Eli Lilly To Give a Keynote Presentation on "Partnering with Lilly Oncology: Current Priorities, NYC Innovation Hub Model & Possible Future States" at the 3rd Oncology Partnering & Deal-Making Conference to be held on July 7-8, 2014 in Boston, MA. This presentation will outline what sorts of assets & platforms that Lilly Oncology is currently prioritizing while also providing a glimpse of our internal process for assessing a biotech's innovation for fit with Lilly's portfolio and long-range strategy.

Eli Lilly to Speak at Metabolomics Meeting, May 22-23 2014, Cambridge, MA

Vladimir Tolstikov, Scientist, Tailored Therapeutics at Eli Lilly is scheduled to give a presentation on "Clinical Metabolomics: Case Study CKD. Cross-platform Omics Data Integration in Ingenuity Systems" at the Inaugural Metabolomics Conference - Advances & Applications in Human Disease to be held in Cambridge, MA on May 22-23, 2014 by GTCBio.

Terry Gaasterland to Speak at Bioinformatics Conference Jun 19-20 2014, San Diego, CA

Terry Gaasterland, Professor of Computational Biology and Genomics at University of California, San Diego will give a presentation on "Integrating exome sequencing, mRNA-seq, and microRNA-seq to identify genes and mechanisms in optic nerve degeneration" at the Bioinformatics & Pharmacogenomics: Managing and Analyzing Big Data Conference to be held in San Diego, CA on June 19-20, 2014 by GTCBio.

Deepak Rajpal to Speak at Bioinformatics Conference Jun 19-20 2014, San Diego, CA

Deepak Rajpal, director at GlaxoSmithKline in the computational biology group at Research Triangle Park, North Carolina, will give a featured presentation on "Integrative Analyses for Drug Discovery Programs" at the Bioinformatics & Pharmacogenomics: Managing and Analyzing Big Data Conference to be held in San Diego, CA on June 19-20, 2014 by GTCbio.

Richard Beger, FDA to Keynote at Metabolomics Conference on May 22-23, 2014 in Cambridge, MA

Richard Beger, Director of the Biomarkers and Alternative Models Branch Division of Systems Biology at the National Center for Toxicological Research, FDA to give a keynote presentation on "Metabolomics of Acetaminophen Overdose in Rodents and Children" at the Metabolomics Conference - Advances & Applications in Human Disease to be held on May 22-23, 2014 in Cambridge, MA by GTC.

Ramesh K. Ramanathan, TGen to Speak at Next Gen Seq Meeting, June 19-20, 2014

Ramesh K. Ramanathan, MD, Medical Director of the Virginia G. Piper Cancer Center (VGPCC) Clinical Trials Program at Scottsdale Healthcare; Senior Investigator and Deputy Director of Translational Research Division at TGen To Give a Featured Presentation at the Next Generation Sequencing Conference on June 19-20, 2014 in San Diego, CA.